Skip to content

Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05854420
Enrollment
68
Registered
2023-05-11
Start date
2018-05-01
Completion date
2021-03-15
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Entropion

Brief summary

This study aims to assess the combination of anterior lamellar recession (ALR) with blepharoplasty, suprasternal fixation, and internal eyelash bulb extirpation of aberrant lashes posteriorly located in patients with any grade of upper eyelid trachomatous cicatricial entropion

Interventions

PROCEDUREModified anterior Lamellar Recession

ALR is one of the procedures used to treat cicatricial entropion and trichiasis. Few studies present the effect of modifications to this procedure in trachomatous entropion and trichiasis. Because trachoma is common in our country, there is a probability that the number of surgeries for TT will rise.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* All patients presented with upper lid trachomatous cicatricial entropion associated with rubbing lashes. * Patients having a history of argon laser ablation, electrolysis, epilation, or past unsuccessful surgery were also included

Exclusion criteria

* Patients with a follow-up period of fewer than 12 months. * Patients with very severe UCE and required posterior lamellar grafts. * Patients with etiology other than trachoma. * Patients with dysplastic lashes without entropion were excluded

Design outcomes

Primary

MeasureTime frameDescription
Success rate3 months post operativeThe cases will be considered succeed if there is no recurrence of the entropion

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026